Elevated chemerin levels show the interlinking of metabolic syndrome and obesity by producing pathophysiological complications such as increased fat, glucose, lipid metabolism, inflammation, and elevated blood pressure that lead to hyperlipidemia and insulin resistance. This evidence concerns the gene RARRES2 and obesity due to melanocortin 4 receptor deficiency.